Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Report any CAM adverse effects, warns Dr Geraldine Moses
Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.
Military medicine
Squadron Leader Michael Whitney MPS, an avid traveller on and off duty, tells AP about his career path in the Defence Force.
Deprescribing in aged care
Deprescribing antipsychotics can be a tricky task. AP talks to four pharmacists who have mastered the art.
The trial that could revolutionise medicine safety
Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.
Chronic pain – the role of pharmacists
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
Oxford Uni vaccine ‘highly effective’ against COVID-19
The University of Oxford/AstraZeneca vaccine, which is easier to transport and cheaper to produce than other vaccine candidates, is ‘highly effective’, late stage trials of the vaccine have shown.
